Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Convalescent plasma vs standard of care in hospitalized patients with mild COVID-19
2020-001936-86Phase 2Terminated
- Sponsor
- Hannover Medical School
- Start
- Aug 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in coronavirus disease 2019 (COVID-19) comparing Convalescent plasma + standard of care with Standard of care alone (2 arms). Primary endpoint: Proportion of patients with treatment failure on day 14. Started Aug 2020; status: terminated.
02
Drugs
COVID-19 convalescent plasma
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-001936-86.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001936-86.